Brontuss
Product Images NDC 49963-913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brontuss (NDC 49963-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Portal Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brontuss Dx Packaging (Mm1)

Brontuss Dx Packaging (Mm1)
Brontuss DX oral liquid label from Portal Inc., NDC 49963-913-04, indicates a 4 oz (118 mL) bottle. The label highlights its use as an antitussive, expectorant, and decongestant with active ingredients per 5 mL: Dextromethorphan HBr 20 mg, Guaifenesin 200 mg, and Phenylephrine HCl 10 mg. The formula is dye, sugar, alcohol, and gluten free.*
FDA Label Image

Brontuss Dx Packaging (Mm2)

Brontuss Dx Packaging (Mm2)
Drug Facts panel for Brontuss DX detailing warnings, do not use conditions, advice to ask a doctor before use, stop use conditions, pregnancy warnings, dosage directions for adults, children 6 to under 12, and children under 6 (not recommended). It includes inactive ingredients, storage instructions, a contact number for questions and comments, and manufacturer information for Portal Pharmaceutical in Mayaguez, PR. The panel also contains a barcode.*
FDA Label Image

Brontuss Dx Packaging (Mm3)

Brontuss Dx Packaging (Mm3)
Brontuss DX oral solution 15 mL packaging label showing active ingredients: Dextromethorphan HBr 20 mg, Guaifenesin 200 mg, and Phenylephrine HCl 10 mg per 5 mL dose. The label notes it is an antitussive, expectorant, and decongestant, dye-free, sugar-free, alcohol-free, gluten-free, and a professional sample not for sale. Manufactured by Portal Pharmaceutical in Mayagüez, PR.*
FDA Label Image

Brontuss Dx Packaging (Mm4)

Brontuss Dx Packaging (Mm4)
Drug Facts panels for Brontuss DX by Portal Inc. include active ingredients dextromethorphan hydrobromide 20 mg, guaifenesin 200 mg, and phenylephrine hydrochloride 10 mg per 5 mL teaspoonful. The text covers uses, warnings, directions, dosage instructions by age group, contraindications, storage conditions, inactive ingredients, and contact information for the manufacturer Portal Pharmaceutical. The label also notes the product is an antitussive, expectorant, and decongestant, and includes a professional sample caution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.